Sentences with phrase «public cycling programs»

Other cities with large public cycling programs on the horizon include Philadelphia, Phoenix, Pittsburgh, and Seattle.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The emergence of industrial civilization, in other words, called forth a federal apparatus sufficient to the need to regulate the private sector in the public interest, to provide macroeconomic stability amidst the uncertainties of the business cycle, and to offer the nation's citizens welfare and security programs appropriate to the vicissitudes of modern life.

Discussions about eggs, social species of animals and life cycle are all regular parts of public programming days when we are around the quails.

DiNapoli, a public financing supporter who had initially recommended a pilot program for the comptroller's race, had blasted the system approved by Cuomo and the Legislature for being developed in the middle of the election cycle.

State Comptroller Tom DiNapoli, a long time supporter of public finance, says this plan comes too late in the election cycle, and relies on the State Board of Elections, a board widely viewed as incompetent, to set up the program.

Levine, another Manhattan Democrat who also did not participate in the public funds program, raised $ 439,110 over the course of the election cycle.

The dysfunctional state Board of Elections is inadequately prepared to implement a public financing program for the comptroller's office this election cycle.

Incumbent Democratic Comptroller Tom DiNapoli is not participating in the public financing program, blasting the system approved by Gov. Andrew Cuomo and state lawmakers for coming in the middle of an election cycle.

We have made a major breakthrough to end this cycle of failure by partnering with Catholic Charities, Buffalo Public Schools and the Say Yes program.

DiNapoli, a long time supporter of public finance, says this plan comes too late in the election cycle, and relies on the State Board of Elections, a board widely viewed as incompetent, to set up the program.

«Despite its intent,» said Rachel Bloom, director of public policy and programs, «the introduction of the bill at this late stage in the municipal election cycle is a deviation of the carefully measured process by which the program is updated and revised.»

Recent Activity RCP Assesses Mississippi Program's Novel Public Health and Community Engagement Partnership In March 2017, RCP conducted an assessment of the Mississippi IDeA Network for Biomedical Research Excellence (Mississippi INBRE) program, a five - year cycle - competitive $ 20 million NIH - funded program designed to enhance biomedical research capacity throughout theProgram's Novel Public Health and Community Engagement Partnership In March 2017, RCP conducted an assessment of the Mississippi IDeA Network for Biomedical Research Excellence (Mississippi INBRE) program, a five - year cycle - competitive $ 20 million NIH - funded program designed to enhance biomedical research capacity throughout theprogram, a five - year cycle - competitive $ 20 million NIH - funded program designed to enhance biomedical research capacity throughout theprogram designed to enhance biomedical research capacity throughout the state.

After unsuccessfully lobbying to change those rules, Illingworth instead helped create a new «Early Release Science» (ERS) program to circumvent them — up to 500 hours of diverse observations front - loaded to Cycle 1 for immediate release to the public, giving all astronomers a chance to absorb the results and apply lessons learned to Webb proposals of their own.

Public knowledge of and support for such programs are essential to breaking the cycle of crime that the current prison system perpetuates.

The U.S. Global Change Research Program, which coordinates the National Climate Assessment report process, also released draft versions of two other reports for public comment: the Second State of the Carbon Cycle Report and the Fourth National Climate Assessment.

A total of $ 200,000 will be available in the 2018 - 19 DEG funding cycle for eligible Wyoming public school districts, community colleges and the University of Wyoming for the development and maintenance of distance education Virtual 307 programs offered by school districts.

In addition to an ongoing program of concerts and theatrical production open to the general public, the Walter Phillips Gallery offers an extensive yearly cycle of stimulating world - class art exhibits and installations.

Artadia provided ample information about the awards cycle via one in - person and two online info sessions, one of which concentrated on best studio visit practices and featured past Artadia juror Sandra Jackson - Dumont, Deputy Director for Education and Public Programs at the Seattle Art Museum.

Each cycle focuses on three cities around the world and comprises high - profile public conferences and residency programs that provide in - depth insight into cities through the lens of local experts and initiate new projects designed to tackle key urban issues.

The cycle culminates in IdeasCity New York, a major international event in which the ideas developed during the cycle's earlier public conferences and residency programs are presented in New York.

For this program, curator and historian Lowery Stokes Sims will lead an hour - long public discussion in the gallery - situated studio of Maria Hupfield, currently featured as an artist - in - residence in Cycle 2 of Studio Views: Craft in the Expanded Field.

Not all of the specific efforts and programs to achieve those goals are in place, since utility programs and efforts are only approved by the California Public Utilities Commission in three - year cycles.

The US Global Change Research Program (USGCRP) released three major reports this afternoon: the final Climate Science Special Report (CSSR), the public review draft of the Fourth National Climate Assessment (NCA4) and the public review draft of the 2nd State of the Carbon Cycle Report (SOCCR - 2).

Typically, the participants in such a program are city dwellers whose transportation needs are largely met by public transit, walking, or cycling.

Members can use their cards to unlock bikes in any of the other public B - cycle programs.

Our partners include the Boston Bikes» Roll It Forward program, CYCLE Kids in Cambridge, the Somerville Public Schools and other groups.

• Qualified to facilitate partnerships with appropriate public and private agencies that provide services to students and families • Effectively able to design meaningful, inclusive and creative activities needed for each cycle of programming guidelines of community school values • Demonstrated ability to handling assessments of participants and program evaluations

Tags for this Online Resume: Strategic Alliance Development, IT Infrastructure, IT Design, Sales Cycle Management, Software Development, Account Management, Territory Management, Change Management, Strategic Planning, Team Leadership, Motivation, Sales Forecasting, Contract Negotiations, Sales Pipeline, Market Analysis, Branding, Presentations, Public Relations, Go - To - Market Solutions, Cloud - based Products, Executive Escalation, Cross-Industry, People Management, Budget Management, Large - Scale Partner Management Programs, Client Relations, Business Development, Project Management, IBM, OEM, Antioch, CA, California, 94531, Assistant Vice President, AVP, Strategic Partnership, ISV

Pay once and have access to any program that yourceus.com offers during the licensure cycle - with advance notification and reserved seating that allows you to save a spot in any training before it is posted and made available to the public.

Researchers estimate that the gains made by Spanish - speaking children are comparable to those made in the landmark Perry Preschool Project and the Abecedarian project, both of which have documented long - term gains for children throughout their life cycles, including reduced crime and teen pregnancy, higher earnings, and reduced participation in public assistance programs.

These benefits, which accrue to both individuals and the public at large, are mostly due to improved long - term outcomes among children who participate in high - quality early learning programs: they are more likely to be high school graduates, attend postsecondary education, and own assets (such as a home)-- and they are less likely to be caught up in the cycle of mass incarceration.